In NRG-GY018/KEYNOTE-868, KEYTRUDA in combination with carboplatin and paclitaxel, followed by KEYTRUDA as a single agent, ...

Merck's Keytruda now approved by European Commission for new gynecologic cancer indications, expanding its reach in the EU.

The European Commission (EC) has approved two new indications for Keytruda (pembrolizumab), Merck & Co’s anti-PD-1 therapy, ...

The acquisition strengthens Merck's oncology portfolio as the company looks to off the expiration of the patent for ...

When Terri Rau was diagnosed with breast cancer decades after being treated for Hodgkin lymphoma, she partnered with her ...

Leerink Partners analyst Jonathan Chang reiterated a Buy rating on Bicycle Therapeutics (BCYC – Research Report) yesterday and set a ...

Interim data from ongoing trial of PRT3789 showed additional clinical activity at higher doses in patients with non-small cell lung cancer ...

On CGEN's third-quarter 2024 earnings call, investors' focus is likely to be on updates on its pipeline candidates being studied for cancer immunotherapies.

Hallmark is excited to announce the launch of Gift Card Greetings.  Available now, the line combines a physical greeting card ...

Finshark, one of the Nordics' leading providers of online banking payments, real-time payouts, and financial insights, has taken a significant step forward in its mission to offer the most secure and ...

Camrelizumab (formerly known as HR 301210, INCSHR 1210, SHR 1210) is a humanised high-affinity IgG4-kappa monoclonal antibody ...

Detailed price information for Cue Biopharma Inc (CUE-Q) from The Globe and Mail including charting and trades.